This policy has been revised by the policy posted on February 1, 2008.

POLICY STATEMENT

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

PEDIATRICS Vol. 101 No. 1 January 1998, p. e13

ELECTRONIC ARTICLE:
Drugs for Pediatric Emergencies

Committee on Drugs

This statement provides current recommendations about the use of emergency drugs for acute pediatric problems that require pharmacologic intervention. At each clinical setting, physicians and other providers should evaluate drug, equipment, and training needs. The information provided here is not all-inclusive and is not intended to be appropriate to every health care setting. When possible, dosage recommendations are consistent with those in standard references, such as the Advanced Pediatric Life Support (APLS) and Pediatric Advanced Life Support (PALS) textbooks. Additional guidance is available in the manual Emergency Medical Services for Children: The Role of the Primary Care Provider, published by the American Academy of Pediatrics, as well as in the PALS and APLS textbooks.


The following policy statement is a revision:

Preparing for Pediatric Emergencies: Drugs to Consider
Mary A. Hegenbarth and the Committee on Drugs
Pediatrics 2008 121: 433-443. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
PediatricsHome page
J. R. Meurer, E. M. Kuhn, V. George, J. S. Yauck, and P. M. Layde
Charges for Childhood Asthma by Hospital Characteristics
Pediatrics, December 1, 1998; 102 (6): e70 - e70.
[Abstract] [Full Text] [PDF]